Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

CellVoyant, an AI-first biotech based in Bristol UK,  today launches FateView™, the first online predictive cell analytics platform designed to help cell-based therapeutic drug developers reduce costs ...

Maxwell has officially signed a full-line supply contract for Perovskite/SHJ tandem cells with a Chinese new energy company, ...